Early first cancer in BRCA1/2 ups risk in opposite breast

Early first cancer in <i>BRCA1/2</i> ups risk in opposite breast

(HealthDay)—BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal of Clinical Oncology.

Alexandra J. van den Broek, from the Netherlands Cancer Institute in Amsterdam, and colleagues examined overall and age-specific estimates of CBC risk for young patients with breast cancer with or without BRCA1/2 mutations. Data were included for 6,294 patients with diagnosed under 50 years of age and treated between 1970 and 2003; participants were tested for the most prevalent BRCA1/2 mutations.

The researchers identified 578 CBCs in the study population after a median follow-up of 12.5 years. Compared with noncarriers, BRCA1 and BRCA2 mutation carriers had significantly increased CBC risk (hazard ratios, 3.31 and 2.17, respectively). The 10-year cumulative CBC risks were 21.1, 10.8, and 5.1 percent, respectively, for BRCA1 carriers, BRCA2 carriers, and noncarriers, respectively. In BRCA1/2 carriers only, age at diagnosis of first was a significant predictor of CBC risk; the 10-year cumulative CBC risk was 23.9 percent in those diagnosed before age 41 years, compared with 12.6 percent for those aged 41 to 49 years (P = 0.02).

"Considering the available evidence, -specific risk estimates should be included in counseling," the authors write.

One author disclosed financial ties to Agendia NV.


Explore further

Risk for developing new cancer in other breast increased for survivors with BRCA mutation

More information: Abstract
Full Text
Journal information: Journal of Clinical Oncology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Early first cancer in BRCA1/2 ups risk in opposite breast (2015, December 30) retrieved 11 April 2021 from https://medicalxpress.com/news/2015-12-early-cancer-brca12-ups-breast.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
37 shares

Feedback to editors

User comments